Better Therapeutics Inc (BTTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,760 | -40,335 | -6,387 | N/A | N/A |
| Depreciation Amortization | 2,729 | 1,619 | 75 | N/A | N/A |
| Income taxes - deferred | 0 | -152 | 152 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,512 | 1,009 | 181 | N/A | N/A |
| Other Working Capital | 6,268 | -2,339 | 306 | N/A | N/A |
| Other Operating Activity | 321 | 9,380 | -101 | 0 | 0 |
| Operating Cash Flow | $-28,930 | $-30,818 | $-5,774 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,180 | -1,071 | -2,305 | N/A | N/A |
| Investing Cash Flow | $-1,180 | $-1,071 | $-2,305 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 87,720 | 7,445 | N/A | N/A |
| Common Stock Issued | 284 | 1 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -14,871 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -518 | 0 | 0 | 0 |
| Financing Cash Flow | $5,284 | $72,332 | $7,445 | $N/A | $N/A |
| Beginning Cash Position | 40,566 | 123 | 757 | N/A | N/A |
| End Cash Position | 15,740 | 40,566 | 123 | N/A | N/A |
| Net Cash Flow | $-24,826 | $40,443 | $-634 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,930 | -30,818 | -5,774 | N/A | N/A |
| Capital Expenditure | -1,180 | -1,071 | -2,305 | N/A | N/A |
| Free Cash Flow | -30,110 | -31,889 | -8,079 | 0 | 0 |